- Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
Rossella Fasano et al, 2021, Life CrossRef - Engineering In Vitro Organ‐Structured Tumor Model for Evaluating Neoantigen‐Specific T Cell Responses in Hepatocellular Carcinoma
Jingyu Xiao et al, 2023, Advanced Materials Interfaces CrossRef - Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review
Kyoko Oura et al, 2021, International Journal of Molecular Sciences CrossRef - Prospects for immunotherapy as a novel therapeutic strategy against hepatocellular carcinoma
Yu Akazawa et al, 2019, World Journal of Meta-Analysis CrossRef - Next-Generation Cancer Immunotherapy Targeting Glypican-3
Yasuhiro Shimizu et al, 2019, Frontiers in Oncology CrossRef - Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes
YU SAWADA et al, 2015, International Journal of Oncology CrossRef - Developments in cancer vaccines for hepatocellular carcinoma
null null et al, 2016, Cancer Immunology, Immunotherapy CrossRef - From bench to bed: the tumor immune microenvironment and current immunotherapeutic strategies for hepatocellular carcinoma
Yaojie Fu et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef - Umbilical cord blood-derived dendritic cells infected by adenovirus for SP17 expression induce antigen-specific cytotoxic T cells against NSCLC cells
Yang Liu et al, 2015, Cellular Immunology CrossRef - Glypican 3 overexpression in primary and metastatic Wilms tumors
Maria Tretiakova et al, 2015, Virchows Archiv CrossRef - Trial Watch: Peptide-based anticancer vaccines
Jonathan Pol et al, 2015, OncoImmunology CrossRef - Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice
Xiaoxiao Jin et al, 2022, Cancer Immunology, Immunotherapy CrossRef - Enhanced specific antitumor immunity of dendritic cells transduced with the glypican 3 gene and co-cultured with cytokine-induced killer cells against hepatocellular carcinoma cells
YULIANG WANG et al, 2015, Molecular Medicine Reports CrossRef - Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
Li Wang et al, 2015, Hepatobiliary & Pancreatic Diseases International CrossRef - Promising new strategies for hepatocellular carcinoma
Yasunari Nakamoto, 2017, Hepatology Research CrossRef - Cancer immunotherapy‐targeted glypican‐3 or neoantigens
Yasuhiro Shimizu et al, 2018, Cancer Science CrossRef - Trial Watch
Fernando Aranda et al, 2013, OncoImmunology CrossRef - Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
Yasuhiro Shimizu et al, 2019, Cancer Science CrossRef - Role of immunotherapies and stem cell therapy in the management of liver cancer: A comprehensive review
Fares E.M. Ali et al, 2024, International Immunopharmacology CrossRef - Selection of highly responsive T cell receptors by an analysis combining the expression of multiple markers
My Thi Viet Ha et al, 2023, Cancer Science CrossRef